| Literature DB >> 24587197 |
Maria Strazzullo1, Bianca Gasparrini2, Gianluca Neglia2, Maria Luisa Balestrieri3, Romina Francioso4, Cristina Rossetti1, Giovanni Nassa5, Maria Rosaria De Filippo6, Alessandro Weisz5, Serena Di Francesco2, Domenico Vecchio2, Maurizio D'Esposito4, Michael John D'Occhio7, Luigi Zicarelli2, Giuseppe Campanile2.
Abstract
The transcriptome profiles were compared for buffalo embryos with normal growth and embryos with retarded growth on Day 25 after mating. Embryos with retarded growth on Day 25 after mating have a reduced likelihood of undergoing attachment to the uterine endometrium and establishing a pregnancy. Italian Mediterranean buffaloes were mated by AI and on Day 25 underwent trans-rectal ultrasonography to ascertain embryo development. Embryos with an embryonic width (EW)>2.7 mm were classed as normal embryos and embryos with an EW<2.7 mm were classed as retarded embryos. Three buffaloes with embryos of the largest EW (3.7, 3.7 and 3.9 mm) and three buffaloes with embryos of the smallest EW (1.5, 1.6 and 1.9 mm) were slaughtered on Day 27 to recover embryos for transcriptome analysis using a bovine custom designed oligo array. A total of 1,047 transcripts were differentially expressed between embryos with normal growth and embryos with retarded growth. Retarded embryos showed 773/1,047 (74%) transcripts that were down-regulated and 274/1,047 (26%) transcripts that were up-regulated relative to normal embryos; in silico analyses focused on 680/1,047 (65%) of the differentially expressed transcripts. The most altered transcripts observed in retarded embryos were associated with membrane structure and function and with metabolic and homeostasis maintenance functions. Other notable functions altered in retarded embryos were developmental processes and in particular nervous system differentiation and function. Specific biochemical pathways such as the complement cascade and coagulation were also altered in retarded embryos. It was concluded from the findings that buffalo embryos with retarded growth on Day 25 after mating show altered gene expression compared with normal embryos, and some de-regulated functions are associated with attachment to the uterine endometrium.Entities:
Mesh:
Year: 2014 PMID: 24587197 PMCID: PMC3938533 DOI: 10.1371/journal.pone.0090027
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Accession number (a), Gene Symbol (b), primers sequence (c), amplicon length (d) and Tm (e) of transcripts validated in qPCR experiments.
| a | b | c | d | e |
| NM_001035325 |
| F 5′ | 130 bp | 64° |
| NM_174137 |
| F 5′ | 206 bp | 64° |
| NM_001079629 |
| F 5′ | 102 bp | 64° |
| NM_001192095 |
| F 5′ | 109 bp | 60° |
| NM_001077864 |
| F 5′ | 217 bp | 64° |
| NM_173908 |
| F5′TGTGAAGGCCCTGCCTACCTCC 3′ R5′ | 102 bp | 64° |
| NM_001101065 |
| F 5′ | 104 bp | 64° |
| NM_001166616 |
| F 5′CGCAAACGCAGATGACACCCG 3′ R 5′ | 200 bp | 62° |
| NM_001075923 |
| F 5′ | 117 bp | 60° |
| NM_001192214 |
| F 5′ | 98 bp | 58° |
| GU324291 |
| F 5′ TCACTGGCATGGCCTTCCGC3′ R 5′ | 122 bp | 60° |
Figure 1Microarray hybridization experiments.
Panel A and panel B show the correlation of the results among the three samples of each group (respectively ctrl = normal embryos and sample = retarded embryos); Panel C depicts the heat map corresponding to some differential expressed transcripts. The number 1, 2, 3 refer to retarded embryo samples; Panel D shows the relative fold change of some differential expressed transcripts.
Figure 2qPCR microarray data validation.
Graph of qPCR data for selected genes compared to corresponding microarray data. The results are expressed as the mean + standard deviation of the relative expression of each transcript.
Figure 3Bioinformatic data analysis.
The results of the SP/PIR TOOL analysis of the data are summarized and the class and percentage of transcripts are reported.
Gene Ontology analysis for molecular functions, subclasses, and percentage, of the differentially expressed genes (DEGs), for normal and retarded buffalo embryos on Day 27 of development.
| Molecular function | Subclasses | DEGs (%) |
| Developmental process | Ion/cation transport; Neuron differentiation; Cell adhesion; Oxidation reduction | 25.0 |
| Homeostatic process | Neurological processes; Ion homeostasis; Regulation of hormone levels; Cell-cell signalling | 16.3 |
| Cell differentiation | Cellular process; Cellular component biogenesis; Biological regulation | 15.0 |
| Nervous system development | Cell differentiation; Neurogenesis | 12.7 |
| Morphogenesis | Multicellular organismal development; Cellular component morphogenesis | 11.9 |
| Response to external stimuli | Response to stress; Response to chemical stimuli; Response to wounding; Inflammatory response; Blood coagulation | 10.1 |
| Organic acid metabolic process | Biosynthetic process; Amino acid metabolic process; Lipid metabolic process | 7.5 |
Figure 4Lipid metabolism network.
The scheme shows the altered transcripts involved in lipid metabolism pathways (according to IPA algorithm). The putative cellular and extracellular localization of each transcript is also shown. The colour of each transcript indicates the expression status: the colour scale from green to red indicates the degree of down- and up-regulation respectively. The legend of shapes correspondence is also reported.
Coagulation/complement cascade genes.
| Gene Symbol | Description | Direction of change |
|
| CD55 molecule, decay accelerating factor for complement | +2.04 |
|
| carboxypeptidase B2 (plasma) | −3.25 |
|
| coagulation factor II (thrombin) | −1.88 |
|
| coagulation factor IX | −3.9 |
|
| coagulation factor XIII, B polypeptide | −4.86 |
|
| complement component 5 | −2.24 |
|
| complement component 8, alpha polypeptide | −1.70 |
|
| complement component 8, beta polypeptide | −1.72 |
|
| fibrinogen beta chain | −1.59 |
|
| mannose-binding lectin (protein C) 2, soluble | −1.54 |
|
| plasminogen | −1.89 |
|
| plasminogen activator, urokinase | +1.76 |
|
| SERPINE peptidase inhibitor, clade A (antitrypsin) 5 | −1.75 |
|
| SERPIN peptidase inhibitor, clade D (heparin cofactor) 1 | −1.97 |
|
| SERPIN peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1) member 1 | +2.16 |
Gene identifier, description, and direction of change, of the differentially expressed genes involved in the coagulation/complement cascade for retarded compared with normal buffalo embryos on Day 27 of development are reported.